Implantable posterior segment drug delivery devices; novel alternatives to currently available treatments

Journal of Ophthalmic and Vision Research

Volumn 4, Issue 3, 2009, Pages 191-193

  Falavarjani, Khalil Ghasemi ^a  

^a Iran University Eye Research Center ^*  (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897748116     PISSN: 20082010     EISSN: 2008322X     Source Type: Journal    
DOI: None     Document Type: Note

References (6)

1. Anand R. Treatment of cytomegalovirus retinitis with the intraocular ganciclovir implant. Curr Opin Ophthalmol 1997;8:8-14.
2. Callanan DG, Jaffe GJ, Martin DF, Pearson PA, Comstock TL. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol 2008;126:1191-1201.
3. Jaffe GJ, McCallum RM, Branchaud B, Skalak C, Butuner Z, Ashton P. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology 2005;112:1192-1198.
4. Jaffe GJ, Martin D, Callanan D, Pearson PA, Levy B, Comstock T, et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis. Ophthalmology 2006;113:1020-1027.
5. Goldstein DA, Godfrey DG, Hall A, Callanan DG, Jaffe GJ, Pearson PA, et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol 2007;125:1478-1485.
6. Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C, et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 2007;125:309-317.